

But with vaccine research centered in high-income countries, and with confirmed cases of Covid-19 increasing rapidly in lower- and middle-income countries, it is important to lay out plans now for ensuring equitable access to, and effective distribution of, a vaccine, or vaccines, once available.Īt a Saturday, June 27, pledging event, “ Global Goal: Unite for Our Future,” hosted by the nongovernmental organization Global Citizen in cooperation with the European Commission, donor governments, foundations, and corporate entities pledged at least $1.3 billion in grants, loans, and guarantees to support the distribution of Covid-19 tests, treatments, and vaccines and ensure that needed tools reach lower- and middle-income countries. For many experts, developing and globally distributing a safe and effective vaccine offers the greatest hope of returning to normal economic and social life.


With more than 12 million confirmed cases of Covid-19 worldwide, and with more than 550,000 deaths attributed to complications from infection with the novel coronavirus, identifying and deploying new diagnostics, treatments, and ways to prevent infection remains critical.
